[1]
Kircik, L., Lebwohl, M., Papp, K., Gooderham, M., Stein Gold, L., Draelos, Z., Kempers, S., Tyring, S., Albrecht, L., Wiseman, M., Ferris, L., Smith, K., Higham, R., Navale, L., Welgus, H. and Berk, D. 2020. Roflumilast Cream (ARQ-151) 0.15% and 0.3% Improved Burden of Signs and Symptoms in Adults With Chronic Plaque Psoriasis in a Phase 2b Study. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s70. DOI:https://doi.org/10.25251/skin.4.supp.70.